Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 40Years
All Genders
NCT05560477

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Led by University of Cincinnati · Updated on 2026-05-04

74

Participants Needed

3

Research Sites

213 weeks

Total Duration

On this page

Sponsors

U

University of Cincinnati

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this clinical trial is to assess the safety and efficacy of AM3101 to facilitate meniscal repair and reduce the incidence of non-healing complications and morbidities associated with a failed meniscal repair. This is a prospective, randomized, controlled, double-blinded, multi-center study.

CONDITIONS

Official Title

Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

Who Can Participate

Age: 18Years - 40Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 to 40 years at screening
  • MRI evidence of ACL plus meniscus tear, or isolated meniscus tear
  • Body mass index (BMI) of 40 kg/m2 or less
  • Normal liver and kidney function at screening
  • Willing and able to comply with study procedures and visits
  • Able to sign informed consent approved by IRB
Not Eligible

You will not qualify if you...

  • Any ligament injury requiring surgery other than ACL
  • History of previous meniscus injury needing treatment or surgery
  • Arthritis Grade III or higher in the affected compartment
  • Elevated AST or ALT liver enzymes at screening
  • Pregnant, nursing, or planning pregnancy during the study
  • Current or recent (past year) drug or alcohol dependence
  • Participation in another clinical study within the last 90 days or planned during this study
  • Medical conditions or impairments preventing follow-up or rehabilitation
  • Conditions preventing proper evaluation of the investigational product
  • Known allergy to simvastatin
  • Current use of simvastatin or other statin drugs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

University of Cincinnati

Cincinnati, Ohio, United States, 45267

Actively Recruiting

2

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Actively Recruiting

3

Oregon Health & Science University

Portland, Oregon, United States, 97239

Actively Recruiting

Loading map...

Research Team

K

Kimberly A Hasselfeld, MS

CONTACT

R

Rebekah West

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here